Balance Sheet
Cash Flow Statement
Cash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in CashChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Sales and DivestituresNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Molecular Partners Ag (MOLN) Cash from Operations: 2020-2025

Historic Cash from Operations for Molecular Partners Ag (MOLN) over the last 5 years, with Sep 2025 value amounting to $37.7 million.

  • Molecular Partners Ag's Cash from Operations fell 0.25% to $37.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$66.4 million, marking a year-over-year decrease of 2.18%. This contributed to the annual value of -$67.3 million for FY2024, which is 2.51% down from last year.
  • Per Molecular Partners Ag's latest filing, its Cash from Operations stood at $37.7 million for Q3 2025, which was up 203.41% from -$36.4 million recorded in Q2 2025.
  • Molecular Partners Ag's Cash from Operations' 5-year high stood at $156.6 million during Q2 2022, with a 5-year trough of -$156.2 million in Q3 2022.
  • Its 3-year average for Cash from Operations is -$11.9 million, with a median of -$19,533 in 2024.
  • Within the past 5 years, the most significant YoY rise in Molecular Partners Ag's Cash from Operations was 635.85% (2022), while the steepest drop was 373.36% (2022).
  • Molecular Partners Ag's Cash from Operations (Quarterly) stood at -$98.6 million in 2021, then spiked by 224.73% to $122.9 million in 2022, then crashed by 154.07% to -$66.5 million in 2023, then dropped by 1.67% to -$67.6 million in 2024, then declined by 0.25% to $37.7 million in 2025.
  • Its last three reported values are $37.7 million in Q3 2025, -$36.4 million for Q2 2025, and -$18,997 during Q1 2025.